| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/14/2002 | CA2418950A1 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | CA2418936A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | CA2418834A1 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | CA2418779A1 Schizophrenia related gene and protein |
| 02/14/2002 | CA2418746A1 Gene expression from the internal ribosome entry site (ires) of rhopalosiphum padi virus (rhpv) |
| 02/14/2002 | CA2418445A1 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | CA2418436A1 Methyl-d-erythritol phosphate pathway genes |
| 02/14/2002 | CA2418386A1 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | CA2418370A1 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
| 02/14/2002 | CA2418352A1 Assays for alternative lengthening of telomeres |
| 02/14/2002 | CA2418144A1 Urocortin proteins and uses thereof |
| 02/14/2002 | CA2418131A1 Peptides capable of functioning as mimotopes for estradiol analytes |
| 02/14/2002 | CA2418091A1 Virus-like particles and process for producing the same |
| 02/14/2002 | CA2417982A1 Manipulation of arterial-venous identity |
| 02/14/2002 | CA2417970A1 2,5-dkg permeases |
| 02/14/2002 | CA2417969A1 Enhancement of industrial production by increasing substrate transport |
| 02/14/2002 | CA2417915A1 Her-2/neu fusion proteins |
| 02/14/2002 | CA2417909A1 Isolation and use of solid tumor stem cells |
| 02/14/2002 | CA2417866A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/14/2002 | CA2417830A1 Cloning of a yeast alpha-amylase promoter and its regulated heterologous expression |
| 02/14/2002 | CA2417802A1 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | CA2417769A1 Drug metabolizing enzymes |
| 02/14/2002 | CA2417722A1 Mutant trichoderma reesei egiii cellulases dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | CA2417707A1 Sid.rtm. nucleic acids and polypeptides selected from a pathogenic strain of hepatitis c virus and applications thereof |
| 02/14/2002 | CA2417676A1 Sequences for integrin alpha-8 |
| 02/14/2002 | CA2417589A1 Motor proteins and methods for their use |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417569A1 Biosensor arrays and methods |
| 02/14/2002 | CA2417368A1 Suppressor gene |
| 02/14/2002 | CA2417358A1 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/14/2002 | CA2417357A1 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 02/14/2002 | CA2417310A1 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 02/14/2002 | CA2417214A1 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 02/14/2002 | CA2416982A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | CA2416890A1 Therapeutic anti-melanoma compounds |
| 02/14/2002 | CA2416633A1 Enhanced replication of hcv rna |
| 02/14/2002 | CA2415868A1 Systems and methods for authenticating a user to a web server |
| 02/14/2002 | CA2415333A1 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | CA2386103A1 Vascular endothelial growth factor 2 |
| 02/13/2002 | EP1179600A1 Monitoring hybridization during PCR |
| 02/13/2002 | EP1179597A1 Method for producing threonine and isoleucine |
| 02/13/2002 | EP1179596A1 Nuclease |
| 02/13/2002 | EP1179595A1 (r)-2-octanol dehydrogenase, process for producing the enzyme, dna encoding the enzyme and process for producing alcohol by using the same |
| 02/13/2002 | EP1179594A1 Rnp originating in paramyxovirus |
| 02/13/2002 | EP1179593A1 Process for producing recombinant insulin from novel fused protein |
| 02/13/2002 | EP1179592A1 Proteins nectin-3 |
| 02/13/2002 | EP1179591A1 Sodium ion-driven chloride/bicarbonate exchanger |
| 02/13/2002 | EP1179590A1 Meg-3 protein |
| 02/13/2002 | EP1179588A1 Human brain carboxypeptidase b |
| 02/13/2002 | EP1179541A1 Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 02/13/2002 | EP1179540A1 Novel polypeptide |
| 02/13/2002 | EP1179539A1 Novel protein having hemolytic activity and gene encoding the protein |
| 02/13/2002 | EP1179363A2 Fixation of nucleotide derivatives to solid carrier |
| 02/13/2002 | EP1179350A2 Encapsulated cell system for implantation into the human CNS |
| 02/13/2002 | EP1179347A1 Liver function controlling agents |
| 02/13/2002 | EP1179340A2 Compositions for the introduction of polyanionic materials into cells |
| 02/13/2002 | EP1179187A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
| 02/13/2002 | EP1179184A1 Identifying material from a breast duct |
| 02/13/2002 | EP1179182A2 Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 02/13/2002 | EP1179176A1 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods |
| 02/13/2002 | EP1179095A1 Methods for producing modified nucleic acid molecules |
| 02/13/2002 | EP1179094A2 Assay for the detection of paclitaxel resistant cells in human tumors |
| 02/13/2002 | EP1179093A1 Expression of ets-domain proteins in cancer |
| 02/13/2002 | EP1179092A2 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
| 02/13/2002 | EP1179091A1 Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method |
| 02/13/2002 | EP1179090A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 02/13/2002 | EP1179086A2 Methods of identifying therapeutic compounds in a genetically defined setting |
| 02/13/2002 | EP1179085A1 Method for sequencing nucleic acid molecules |
| 02/13/2002 | EP1179083A1 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
| 02/13/2002 | EP1179082A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/13/2002 | EP1179081A1 The rice actin 2 promoter and intron and methods for use thereof |
| 02/13/2002 | EP1179080A1 The maize rs324 promoter and methods for use thereof |
| 02/13/2002 | EP1179079A1 The maize rs81 promoter and methods for use thereof |
| 02/13/2002 | EP1179078A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
| 02/13/2002 | EP1179077A1 Cloned and engineered plants and methods of use for bioremediation |
| 02/13/2002 | EP1179076A1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene |
| 02/13/2002 | EP1179075A2 Bacillus circulans xylanase mutants |
| 02/13/2002 | EP1179074A1 Novel genes encoding wheat starch synthases and uses therefor |
| 02/13/2002 | EP1179073A1 Process for the fermentative preparation of l-amino acids with amplification of the zwf gene |
| 02/13/2002 | EP1179072A2 Combination neisserial compositions |
| 02/13/2002 | EP1179071A2 Regulating organelle homeostasis in a cell factory |
| 02/13/2002 | EP1179070A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 02/13/2002 | EP1179069A1 GENE ISOLATED FROM $i(RICINUS COMMUNIS) ENCODING A NEW PROTEIN THAT INTERACTS WITH THE OLEATE 12-HYDROXYLASE ENZYME |
| 02/13/2002 | EP1179068A1 Interleukin-1 hy2 materials and methods |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179062A2 Nucleic acids and proteins with p53 activity and altered tetramerization domains |
| 02/13/2002 | EP1179061A1 Methods for treating tumors using antiangiogenic compounds |
| 02/13/2002 | EP1179059A1 Isolating biological modulators from biodiverse gene fragment libraries |
| 02/13/2002 | EP1179058A1 Cell concentration and lysate clearance using paramagnetic particles |
| 02/13/2002 | EP1179057A2 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS |
| 02/13/2002 | EP1179056A1 Mixed-bed solid phase and its use in the isolation of nucleic acids |
| 02/13/2002 | EP1179055A1 Novel phytochelatin synthases and uses therefor |
| 02/13/2002 | EP1179054A2 Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| 02/13/2002 | EP1179053A1 Telophase enucleated oocytes for nuclear transfer |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179047A1 Phosphorus-controllable recombinant expression of polypeptides in plants |